Friday, 19 October 2018

Slayback Pharma appoints Dr Girish Jain as Global R&D Head

25 July 2018 | News

Dr Jain is a highly accomplished scientist and a veteran in the field of Pharmaceutical Research and Development.

Image credit- wns.com

Image credit- wns.com

Slayback Pharma LLC, a privately held pharmaceutical research and development company, has announced the appointment of Dr Girish Jain as Senior Vice President and Head of Global R&D. Dr Jain will be based out of Slayback's Hyderabad, India office.

Dr Jain is a highly accomplished scientist and a veteran in the field of Pharmaceutical Research and Development. He is widely recognized in India for his R&D leadership. He has successfully led the development and filing of more than 225 ANDAs with USFDA, across various dosage forms and over 75 different products with Europe and Australia. He is also the lead inventor in scores of granted patents. His experience straddles both the innovative and generic pharmaceutical research space.

Dr Jain has had a stellar leadership track record in the industry. Prior to joining Slayback, he was President and Head of R&D at Alkem for the last four years. Earlier, he served for 10 years at Wockhardt where he was the Senior Vice President and Head of R&D in his last position.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Click Here!




Survey Box

Can blockchain help cease fake drug distribution in India?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls